about
Structural basis for recognition of autophagic receptor NDP52 by the sugar receptor galectin-8Investigation into the feasibility of thioditaloside as a novel scaffold for galectin-3-specific inhibitorsPerdeuteration, crystallization, data collection and comparison of five neutron diffraction data sets of complexes of human galectin-3CStructure-based optimization of angiostatic agent 6DBF7, an allosteric antagonist of galectin-1.How to avoid being eaten: a lymphoma's defense.Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.Galectin-3 inhibitors: a patent review (2008-present).Structural characterisation of human galectin-4 N-terminal carbohydrate recognition domain in complex with glycerol, lactose, 3'-sulfo-lactose, and 2'-fucosyllactose.Galectin-1 inhibitors and their potential therapeutic applications: a patent review.Galectin-1 dimers can scaffold Raf-effectors to increase H-ras nanoclustering.Synthetic glycoconjugates inhibitors of tumor-related galectin-3: an update.Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models.Dissecting the Structure-Activity Relationship of Galectin-Ligand Interactions.Chemical Shifts of the Carbohydrate Binding Domain of Galectin-3 from Magic Angle Spinning NMR and Hybrid Quantum Mechanics/Molecular Mechanics Calculations.Kinetic properties of carbohydrate-lectin interactions: FimH antagonists.The Role of Galectins as Modulators of Metabolism and Inflammation.
P2860
Q27684209-7607E249-9408-4E95-B3C4-C135794C414AQ27685236-2EEED0A8-04D8-42B7-BED4-E0B31EE9F80AQ36191511-0F3F336C-4022-4710-A9E6-3C65F1F0A71CQ36642433-D499BB89-54D0-4FE8-8D66-6C27F42E4211Q36800441-96E4984B-A216-4320-A300-08FE2FC8C475Q38019412-6F8E82A0-EF74-45D3-9B49-D99044ECC13FQ38238525-06617C22-587F-4A0E-83BC-CC9DAABEED66Q38294060-72B6A658-BF87-4DA3-B472-79CE6DCE962EQ38763827-10DB9570-6DBF-4C60-8EA4-3F8A7B50DFBBQ38777463-73542759-D5F8-4D60-A15A-18CCAC454EABQ38928047-7E4D0F3B-EFD4-401E-9FE1-952E29DE4AF6Q47302234-52874165-3D84-4A1F-930D-F4078A09EBF3Q47547850-DC168699-77FD-4A72-AF41-E7798A04EED2Q52677174-980FF042-A9C3-4B0A-BFE3-41EF2F325DBCQ54414284-EB892C02-73D7-4C36-BCBB-5EA877E74DACQ55349770-DB689D31-6549-4D00-BBF1-0BD3F1EC1AE1
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Taloside inhibitors of galectin-1 and galectin-3
@ast
Taloside inhibitors of galectin-1 and galectin-3
@en
Taloside inhibitors of galectin-1 and galectin-3
@nl
type
label
Taloside inhibitors of galectin-1 and galectin-3
@ast
Taloside inhibitors of galectin-1 and galectin-3
@en
Taloside inhibitors of galectin-1 and galectin-3
@nl
prefLabel
Taloside inhibitors of galectin-1 and galectin-3
@ast
Taloside inhibitors of galectin-1 and galectin-3
@en
Taloside inhibitors of galectin-1 and galectin-3
@nl
P2860
P50
P3181
P1476
Taloside inhibitors of galectin-1 and galectin-3
@en
P2093
Christopher T Oberg
P2860
P304
P3181
P356
10.1111/J.1747-0285.2011.01283.X
P577
2012-01-11T00:00:00Z